Expression of vascular endothelial growth factor in normal epidermis, epithelial tumors and cultured keratinocytes

[1]  S. Soker,et al.  Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. , 1995, Cancer research.

[2]  K. Alitalo,et al.  Endothelial receptor tyrosine kinases involved in angiogenesis , 1995, The Journal of cell biology.

[3]  M. Volm,et al.  Vascular endothelial growth-factor expression and angiogenesis in nonsmall cell lung carcinomas. , 1995, International journal of oncology.

[4]  H. Dvorak,et al.  Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. , 1995, The Journal of investigative dermatology.

[5]  G. Howes,et al.  Transforming growth factor‐α expression in in situ epidermal neoplasia , 1995, Clinical and experimental dermatology.

[6]  D. Schmitt,et al.  Expression of adhesion receptors in epidermal tumors: correlation with TNF alpha expressing cells. , 1995, Anticancer research.

[7]  H. Dvorak,et al.  Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis , 1994, The Journal of experimental medicine.

[8]  D. Schmitt,et al.  Effect of nickel on the activation state of normal human keratinocytes through interleukin 1 and intercellular adhesion molecule 1 expression , 1994, The British journal of dermatology.

[9]  C. Frelin,et al.  Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. , 1993, Biochemical and biophysical research communications.

[10]  H. Dvorak,et al.  Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing , 1992, The Journal of experimental medicine.

[11]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[12]  B. Spiegelman,et al.  Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. , 1992, The Journal of biological chemistry.

[13]  H Ueno,et al.  The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. , 1992, Science.

[14]  N. Ferrara,et al.  Molecular and biological properties of the vascular endothelial growth factor family of proteins. , 1992, Endocrine reviews.

[15]  H. Dvorak,et al.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. , 1992, Molecular biology of the cell.

[16]  I. Chou,et al.  An immunofluorescence study of the calcium-induced coordinated reorganization of microfilaments, keratin intermediate filaments, and microtubules in cultured human epidermal keratinocytes. , 1991, The Journal of investigative dermatology.

[17]  J. Fairley Calcium metabolism and the pathogenesis of dermatologic disease. , 1991, Seminars in dermatology.

[18]  J. Fiddes,et al.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.

[19]  D. Connolly,et al.  Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration , 1990, The Journal of experimental medicine.

[20]  A. Gottlieb,et al.  Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes , 1988, The Journal of experimental medicine.

[21]  H. Dvorak,et al.  A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. , 1986, Cancer research.

[22]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[23]  C. Ballaun,et al.  Human keratinocytes express the three major splice forms of vascular endothelial growth factor. , 1995, The Journal of investigative dermatology.